Top

Published in:

Open Access 01-12-2012 | Research

Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control

Authors: Christopher G Pretty, Aaron J Le Compte, J Geoffrey Chase, Geoffrey M Shaw, Jean-Charles Preiser, Sophie Penning, Thomas Desaive

Published in: Annals of Intensive Care | Issue 1/2012

Abstract

Background

Effective tight glycemic control (TGC) can improve outcomes in critical care patients, but it is difficult to achieve consistently. Insulin sensitivity defines the metabolic balance between insulin concentration and insulin-mediated glucose disposal. Hence, variability of insulin sensitivity can cause variable glycemia. This study quantifies and compares the daily evolution of insulin sensitivity level and variability for critical care patients receiving TGC.

Methods

This is a retrospective analysis of data from the SPRINT TGC study involving patients admitted to a mixed medical-surgical ICU between August 2005 and May 2007. Only patients who commenced TGC within 12 hours of ICU admission and spent at least 24 hours on the SPRINT protocol were included (N = 164). Model-based insulin sensitivity (SI) was identified each hour. Absolute level and hour-to-hour percent changes in SI were assessed on cohort and per-patient bases. Levels and variability of SI were compared over time on 24-hour and 6-hour timescales for the first 4 days of ICU stay.

Results

Cohort and per-patient median SI levels increased by 34% and 33% (p < 0.001) between days 1 and 2 of ICU stay. Concomitantly, cohort and per-patient SI variability decreased by 32% and 36% (p < 0.001). For 72% of the cohort, median SI on day 2 was higher than on day 1. The day 1–2 results are the only clear, statistically significant trends across both analyses. Analysis of the first 24 hours using 6-hour blocks of SI data showed that most of the improvement in insulin sensitivity level and variability seen between days 1 and 2 occurred during the first 12–18 hours of day 1.

Conclusions

Critically ill patients have significantly lower and more variable insulin sensitivity on day 1 than later in their ICU stay and particularly during the first 12 hours. This rapid improvement is likely due to the decline of counter-regulatory hormones as the acute phase of critical illness progresses. Clinically, these results suggest that while using TGC protocols with patients during their first few days of ICU stay, extra care should be afforded. Increased measurement frequency, higher target glycemic bands, conservative insulin dosing, and modulation of carbohydrate nutrition should be considered to minimize safely the outcome glycemic variability and reduce the risk of hypoglycemia.

Available only for authorised users

Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong X-W, Lin J, Lotz T, Lee D, Hann C: Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care 2008,12(2):R49. 10.1186/cc6868PubMedCentralPubMedCrossRef

Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006,354(5):449–461. 10.1056/NEJMoa052521PubMedCrossRef

Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001,345(19):1359–1367. 10.1056/NEJMoa011300PubMedCrossRef

Krinsley JS: Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol. Crit Care Med 2003, 31: A19.

Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, et al.: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009,360(13):1283–1297.PubMedCrossRef

Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, et al.: A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009,35(10):1738–1748. 10.1007/s00134-009-1585-2PubMedCrossRef

Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, et al.: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008,358(2):125–139. 10.1056/NEJMoa070716PubMedCrossRef

Chase JG, Le Compte AJ, Suhaimi F, Shaw GM, Lynn A, Lin J, Pretty CG, Razak N, Parente JD, Hann CE, et al.: Tight glycemic control in critical care - The leading role of insulin sensitivity and patient variability: A review and model-based analysis. Comput Methods Programs Biomed 2011,102(2):156–171. 10.1016/j.cmpb.2010.11.006PubMedCrossRef

Egi M, Bellomo R, Stachowski E, French CJ, Hart G: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006,105(2):244–252. 10.1097/00000542-200608000-00006PubMedCrossRef

10.

Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M: Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010,85(3):217–224. 10.4065/mcp.2009.0394PubMedCentralPubMedCrossRef

11.

Krinsley JS: Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008,36(11):3008–3013. 10.1097/CCM.0b013e31818b38d2PubMedCrossRef

12.

Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C: The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009,13(3):R91. 10.1186/cc7921PubMedCentralPubMedCrossRef

13.

Chase JG, Shaw GM, Lotz T, LeCompte A, Wong J, Lin J, Lonergan T, Willacy M, Hann CE: Model-based insulin and nutrition administration for tight glycaemic control in critical care. Curr Drug Deliv 2007,4(4):283–296. 10.2174/156720107782151223PubMedCrossRef

14.

Lonergan T, Le Compte A, Willacy M, Chase JG, Shaw GM, Hann CE, Lotz T, Lin J, Wong XW: A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients. Diabetes Technol Ther 2006,8(4):449–462. 10.1089/dia.2006.8.449PubMedCrossRef

15.

Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM: Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed 2005,77(3):259–270. 10.1016/j.cmpb.2004.10.006PubMedCrossRef

16.

Lin J, Razak NN, Pretty CG, Le Compte A, Docherty P, Parente JD, Shaw GM, Hann CE, Geoffrey Chase J: A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients. Comput Methods Programs Biomed 2011,102(2):192–205. 10.1016/j.cmpb.2010.12.008PubMedCrossRef

17.

Lotz TF, Chase JG, McAuley KA, Shaw GM, Wong XW, Lin J, Lecompte A, Hann CE, Mann JI: Monte Carlo analysis of a new model-based method for insulin sensitivity testing. Comput Methods Programs Biomed 2008,89(3):215–225. 10.1016/j.cmpb.2007.03.007PubMedCrossRef

18.

Evans A, Shaw GM, Le Compte A, Tan CS, Ward L, Steel J, Pretty CG, Pfeifer L, Penning S, Suhaimi F, et al.: Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control. Ann Intensive Care 2011, 1: 38. 10.1186/2110-5820-1-38PubMedCentralPubMedCrossRef

19.

Le Compte A, Chase J, Lynn A, Hann C, Shaw G, Wong X, Lin J: Blood Glucose Controller for Neonatal Intensive Care: Virtual trials development and 1st clinical trials. J Diabetes Sci Technol 2009,3(5):1066–1081.PubMedCentralPubMedCrossRef

20.

Shaw GM, Chase JG, Wong J, Lin J, Lotz T, Le Compte AJ, Lonergan TR, Willacy MB, Hann CE: Rethinking glycaemic control in critical illness - from concept to clinical practice change. Crit Care Resusc 2006,8(2):90–99.PubMed

21.

Chernow B, Alexander HR, Smallridge RC, Thompson WR, Cook D, Beardsley D, Fink MP, Lake CR, Fletcher JR: Hormonal responses to graded surgical stress. Arch Intern Med 1987,147(7):1273–1278. 10.1001/archinte.1987.00370070087013PubMedCrossRef

22.

Weissman C: The metabolic response to stress: an overview and update. Anesthesiology 1990,73(2):308–327. 10.1097/00000542-199008000-00020PubMedCrossRef

23.

Frayn KN: Hormonal control of metabolism in trauma and sepsis. Clin Endocrinol (Oxf) 1986,24(5):577–599. 10.1111/j.1365-2265.1986.tb03288.xCrossRef

24.

Jaattela A, Alho A, Avikainen V, Karaharju E, Kataja J, Lahdensuu M, Lepisto P, Rokkanen P, Tervo T: Plasma catecholamines in severely injured patients: a prospective study on 45 patients with multiple injuries. Br J Surg 1975,62(3):177–181. 10.1002/bjs.1800620303PubMedCrossRef

25.

Black PR, Brooks DC, Bessey PQ, Wolfe RR, Wilmore DW: Mechanisms of insulin resistance following injury. Ann Surg 1982,196(4):420–435. 10.1097/00000658-198210000-00005PubMedCentralPubMedCrossRef

26.

Deibert DC, DeFronzo RA: Epinephrine-induced insulin resistance in man. J Clin Invest 1980,65(3):717–721. 10.1172/JCI109718PubMedCentralPubMedCrossRef

27.

Thorell A, Rooyackers O, Myrenfors P, Soop M, Nygren J, Ljungqvist OH: Intensive insulin treatment in critically ill trauma patients normalizes glucose by reducing endogenous glucose production. J Clin Endocrinol Metab 2004,89(11):5382–5386. 10.1210/jc.2004-1118PubMedCrossRef

28.

Chase JG, Suhaimi F, Penning S, Preiser JC, Le Compte AJ, Lin J, Pretty CG, Shaw GM, Moorhead KT, Desaive T: Validation of a model-based virtual trials method for tight glycemic control in intensive care. Biomed Eng Online 2010, 9: 84. 10.1186/1475-925X-9-84PubMedCentralPubMedCrossRef

29.

Arkray: Glucocard™ Test Strip 2 Data Sheet. Arkray Inc, apan; 2007.

30.

Chase J, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE: Model-based glycaemic control in critical care: a review of the state of the possible. Biomed Signal Proc Control 2006,1(1):3–21. 10.1016/j.bspc.2006.03.002CrossRef

31.

Davidson PC, Steed RD, Bode BW: Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 2005,28(10):2418–2423. 10.2337/diacare.28.10.2418PubMedCrossRef

32.

Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE: Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004,27(2):461–467. 10.2337/diacare.27.2.461PubMedCrossRef

33.

Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH: Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010,38(3):838–842. 10.1097/CCM.0b013e3181cc4be9PubMedCrossRef

34.

Piconi L, Quagliaro L, Assaloni R, Da Ros R, Maier A, Zuodar G, Ceriello A: Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 2006,22(3):198–203. 10.1002/dmrr.613PubMedCrossRef

35.

Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A: Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001,281(5):E924-E930.PubMed

36.

Chase JG, Compte AJL, Preiser J-C, Shaw GM, Penning S, Desaive T: Physiological modeling, tight glycemic control and the ICU clinician: what are models and how can they affect practice? Ann Intensive Care 2011,1(1):11. 10.1186/2110-5820-1-11PubMedCentralPubMedCrossRef

37.

McAuley KA, Berkeley JE, Docherty PD, Lotz TF, Te Morenga LA, Shaw GM, Williams SM, Chase JG, Mann JI: The dynamic insulin sensitivity and secretion test–a novel measure of insulin sensitivity. Metabolism 2011,60(12):1748–1756. 10.1016/j.metabol.2011.05.009PubMedCrossRef

38.

Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE: American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009,32(6):1119–1131. 10.2337/dc09-9029PubMedCentralPubMedCrossRef

39.

Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P: Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011,154(4):260–267.PubMedCrossRef

40.

Ichai C, Preiser JC: International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care 2010,14(5):R166.PubMedCentralPubMed

41.

Lonergan T, LeCompte A, Willacy M, Chase JG, Shaw GM, Wong XW, Lotz T, Lin J, Hann CE: A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther 2006,8(2):191–206. 10.1089/dia.2006.8.191PubMedCrossRef

42.

Krishnan JA, Parce PB, Martinez A, Diette GB, Brower RG: Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 2003,124(1):297–305. 10.1378/chest.124.1.297PubMedCrossRef

43.

Suhaimi F, Le Compte A, Preiser JC, Shaw GM, Massion P, Radermecker R, Pretty CG, Lin J, Desaive T, Chase JG: What makes tight glycemic control tight? The impact of variability and nutrition in two clinical studies. J Diabetes Sci Technol 2010,4(2):284–298.PubMedCentralPubMedCrossRef

44.

Natali A, Gastaldelli A, Camastra S, Sironi AM, Toschi E, Masoni A, Ferrannini E, Mari A: Dose–response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am J Physiol Endocrinol Metab 2000,278(5):E794-E801.PubMed

45.

Prigeon RL, Roder ME, Porte D Jr, Kahn SE: The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest 1996,97(2):501–507.PubMed

46.

Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Lotz T, Wake GC, Broughton B: Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol Ther 2005,7(2):274–282. 10.1089/dia.2005.7.274PubMedCrossRef

47.

Chase JG, Shaw GM, Lin J, Doran CV, Bloomfield M, Wake GC, Broughton B, Hann C, Lotz T: Impact of insulin-stimulated glucose removal saturation on dynamic modelling and control of hyperglycaemia. Int J Intellig Syst Technol Appl (IJISTA) 2004,1(1/2):79–94.

48.

Rubinson L, Diette GB, Song X, Brower RG, Krishnan JA: Low caloric intake is associated with nosocomial bloodstream infections in patients in the medical intensive care unit. Crit Care Med 2004,32(2):350–357. 10.1097/01.CCM.0000089641.06306.68PubMedCrossRef

49.

Cerra FB, Benitez MR, Blackburn GL, Irwin RS, Jeejeebhoy K, Katz DP, Pingleton SK, Pomposelli J, Rombeau JL, Shronts E, et al.: Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest 1997,111(3):769–778.PubMed

50.

Braithwaite SS, Edkins R, Macgregor KL, Sredzienski ES, Houston M, Zarzaur B, Rich PB, Benedetto B, Rutherford EJ: Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions. Diabetes Technol Ther 2006,8(4):476–488. 10.1089/dia.2006.8.476PubMedCrossRef

51.

Preiser JC: Year in review 2008: Critical Care–metabolism. Crit Care 2009,13(5):228. 10.1186/cc8024PubMedCentralPubMedCrossRef

52.

Mesotten D, Van den Berghe G: Clinical benefits of tight glycaemic control: focus on the intensive care unit. Best Pract Res Clin Anaesthesiol 2009,23(4):421–429. 10.1016/j.bpa.2009.08.006PubMedCrossRef

53.

Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, et al.: Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009,180(8):821–827. 10.1503/cmaj.090206PubMedCentralPubMedCrossRef

54.

Lin J, Lee D, Chase JG, Shaw GM, Le Compte A, Lotz T, Wong J, Lonergan T, Hann CE: Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Compt Methods Programs Biomed 2008,89(2):141–152. 10.1016/j.cmpb.2007.04.006CrossRef

55.

Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Robertson MB, Browne PM, Lotz T, Wake GC, Broughton B: Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care. Med Eng Phys 2005,27(1):1–11. 10.1016/j.medengphy.2004.08.006PubMedCrossRef

56.

Wong XW, Singh-Levett I, Hollingsworth LJ, Shaw GM, Hann CE, Lotz T, Lin J, Wong OS, Chase JG: A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther 2006,8(2):174–190. 10.1089/dia.2006.8.174PubMedCrossRef

57.

Wong XW, Chase JG, Shaw GM, Hann CE, Lotz T, Lin J, Singh-Levett I, Hollingsworth LJ, Wong OS, Andreassen S: Model predictive glycaemic regulation in critical illness using insulin and nutrition input: a pilot study. Med Eng Phys 2006,28(7):665–681. 10.1016/j.medengphy.2005.10.015PubMedCrossRef

58.

Chase JG, Wong X-W, Singh-Levett I, Hollingsworth LJ, Hann CE, Shaw GM, Lotz T, Lin J: Simulation and initial proof-of-concept validation of a glycaemic regulation algorithm in critical care. Control Eng Pract 2008,16(3):271–285. 10.1016/j.conengprac.2007.04.009CrossRef

59.

Hann C, Chase J, Ypma M, Elfring J, Nor N, Lawrence P, Shaw G: The Impact of Parameter Identification Methods on Drug Therapy Control in an Intensive Care Unit. Open Med Inform J 2008, 2: 92–104. 10.2174/1874431100802010092PubMedCentralPubMedCrossRef

60.

Cobelli C, Carson ER, Finkelstein L, Leaning MS: Validation of simple and complex models in physiology and medicine. Am J Physiol 1984,246(2 Pt 2):R259-R266.PubMed

61.

Cobelli C, Pacini G, Toffolo G, Sacca L: Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am J Physiol 1986,250(5 Pt 1):E591-E598.PubMed

62.

Carson ER, Cobelli C: Modelling methodology for physiology and medicine. Academic, San Diego; 2001.

63.

Cobelli C, Caumo A, Omenetto M: Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. Am J Physiol 1999,277(3 Pt 1):E481-E488.PubMed

64.

Hovorka R, Chassin LJ, Ellmerer M, Plank J, Wilinska ME: A simulation model of glucose regulation in the critically ill. Physiol Meas 2008,29(8):959–978. 10.1088/0967-3334/29/8/008PubMedCrossRef

65.

Pillonetto G, Sparacino G, Cobelli C: Numerical non-identifiability regions of the minimal model of glucose kinetics: superiority of Bayesian estimation. Math Biosci 2003,184(1):53–67. 10.1016/S0025-5564(03)00044-0PubMedCrossRef

66.

Le Compte AJ, Lee DS, Chase JG, Lin J, Lynn A, Shaw GM: Blood glucose prediction using stochastic modeling in neonatal intensive care. IEEE Trans Biomed Eng 2010,57(3):509–518.PubMedCrossRef

67.

Lin J, Lee D, Chase J, Hann C, Lotz T, Wong X: Stochastic Modelling of Insulin Sensitivity Variability in Critical Care. Biomed Signal Proc Control 2006, 1: 229–242. 10.1016/j.bspc.2006.09.003CrossRef

68.

Lin J, Lee D, Chase JG, Shaw GM, Le Compte A, Lotz T, Wong J, Lonergan T, Hann CE: Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput Methods Programs Biomed 2008,89(2):141–152. 10.1016/j.cmpb.2007.04.006PubMedCrossRef

69.

Lotz TF, Chase JG, McAuley KA, Lee DS, Lin J, Hann CE, Mann JI: Transient and steady-state euglycemic clamp validation of a model for glycemic control and insulin sensitivity testing. Diabetes Technol Ther 2006,8(3):338–346. 10.1089/dia.2006.8.338PubMedCrossRef

70.

Lotz T: High Resolution Clinical Model-Based Assessment of Insulin Sensitivity. University of Canterbury, Christchurch; 2007.

71.

Lin J, Razak NN, Pretty CG, Le Compte A, Docherty P, Parente JD, Shaw GM, Hann CE: Geoffrey Chase J: A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients. Comput Methods Programs Biomed 2011,102(2):192–205. 10.1016/j.cmpb.2010.12.008PubMedCrossRef

72.

McAuley KA, Williams SM, Mann JI, Goulding A, Chisholm A, Wilson N, Story G, McLay RT, Harper MJ, Jones IE: Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial. Diabetes Care 2002,25(3):445–452. 10.2337/diacare.25.3.445PubMedCrossRef

73.

Le Compte A: Modelling the Glucose-Insulin Regulatory System for Glycaemic Control in Neonatal Intensive Care. PhD thesis. University of Canterbury, Christchurch, New Zealand; 2009.

74.

Lin J: Robust Modelling and Control of the Glucose-Insulin Regulatory System for Tight Glycemic Control of Critical Care Patients. University of Canterbury, Christchurch; 2007.

Title: Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control
Authors: Christopher G Pretty
Aaron J Le Compte
J Geoffrey Chase
Geoffrey M Shaw
Jean-Charles Preiser
Sophie Penning
Thomas Desaive
Publication date: 01-12-2012
Publisher: Springer Paris
Published in: Annals of Intensive Care / Issue 1/2012
Electronic ISSN: 2110-5820
DOI: https://doi.org/10.1186/2110-5820-2-17

At a glance: The STEP trials

Springer Medicine

Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Near infrared spectroscopy (NIRS) of the thenar eminence in anesthesia and intensive care

Statins in the critically ill

Management of thrombocytopenia in the ICU (pregnancy excluded)

Systems modeling and simulation applications for critical care medicine

Human metapneumovirus infections on the ICU: a report of three cases

Symptoms of depression in ICU physicians